For the First Time, FDA Wields Additional Import Power

The FDA does not usually grab headlines for making trade paperwork more exciting. That is a job generally reserved for people who enjoy customs codes a little too much. But this time, the agency did something genuinely big: for the first time since the Food Safety Modernization Act gave it the authority back in 2011, the FDA used an additional import power called import certification to tighten control over certain food shipments headed for the United States.

That may sound like the kind of phrase only regulatory lawyers frame and hang on the wall, but the move matters far beyond legal memos. It signals a sharper, more preventive era in FDA import enforcement, one where the agency is not just stopping bad products at the border, but demanding stronger proof before some products even leave the exporting country. In short: less “we’ll check it when it gets here,” and more “show your homework before you ship.”

This first use of FDA’s added import authority grew out of contamination concerns involving shrimp and spices from certain regions of Indonesia. But the implications stretch much further. The decision gives importers, manufacturers, retailers, customs brokers, and food safety teams a preview of how the agency may respond when imported food risks look systemic, recurring, and too serious for business as usual.

What Changed, Exactly?

The big change is that the FDA moved beyond its traditional border tools and required import certification for certain products. Instead of relying only on screening, detention, or sampling after goods arrive, the agency now requires shipment-specific or facility-related assurances that the food meets U.S. standards before admission.

That is a meaningful upgrade in power. Under this approach, affected foods are not simply watched more closely. They must be backed by documentation from entities the FDA recognizes or designates. For the products at issue, that means extra oversight, more structured proof, and less room for a hopeful shrug at the dock.

In plain English, FDA’s message was simple: if a region presents an ongoing food safety risk, the agency can now demand a stronger gatekeeping system before products enter American commerce. That is not a symbolic tweak. It is a more muscular, risk-based enforcement move built directly into the FSMA framework.

Why the FDA Acted Now

The immediate trigger was concern over Cesium-137 contamination in certain imported foods. U.S. Customs and Border Protection detected elevated levels in multiple shrimp shipments and in a sample of cloves from certain Indonesian regions. The FDA then confirmed contamination through testing and reviewed other evidence related to contamination risk in the region.

That set off the sort of regulatory chain reaction nobody wants attached to dinner. Recalls of shrimp followed. Public advisories went out. Import alerts were issued. And then came the bigger step: the FDA decided the situation warranted use of its long-authorized but never-before-used import certification authority.

The affected products were shrimp and all spices from the Island of Java and Lampung Province on Sumatra. The FDA concluded there were known safety risks tied both to the food and to the region of origin. That combination matters because the law allows the agency to impose certification when statutory factors point to an elevated, ongoing risk.

Why This Is Such a Big FDA Moment

For years, the FDA has had a broad set of tools for imported food safety. It can screen entries electronically, inspect shipments, sample products, issue import alerts, and use detention without physical examination. Importers also already face obligations under the Foreign Supplier Verification Program, or FSVP, which requires risk-based checks to confirm that foreign suppliers meet U.S. food safety standards.

So why is this move different? Because import certification adds another layer. It is not merely reactive. It is a targeted requirement for proof tied to the specific risk the agency has identified. The FDA can use it when ordinary controls are not enough to manage a recurring or systemic problem while still allowing compliant trade to continue.

That “while still allowing compliant trade to continue” part is crucial. The agency did not announce a blanket stop on all products from an entire country. Instead, it used a more surgical tool. That makes this action important not only for food safety, but also for trade operations, because it shows the FDA is willing to separate compliant products from suspect ones with more precision.

How Import Certification Works

It Is More Than an Ordinary Import Alert

Import alerts are already serious business. They allow the FDA to place products under detention without physical examination, often called DWPE. That means future shipments can be detained based on the appearance of a violation, even without fresh testing of every shipment. If a product is on the wrong list, you do not just glide through customs with a confident smile and a nice invoice.

But import certification goes further. It can require that a designated certifying entity or an accredited third-party body provide documentation showing the product satisfies applicable FDA requirements. In other words, the burden of reassurance moves upstream. The product must arrive with more than optimism and a packing slip.

Red List, Yellow List, and Extra Oversight

In the FDA’s implementation for the Indonesian shrimp and spice case, the agency used an import alert structure with a Red List and a Yellow List. Firms on the Red List had evidence of contamination in products or processing environments. To get off that list, they needed certification through the Accredited Third-Party Certification Program showing that controls for Cesium-137 had been properly established and verified.

Products associated with broader regional contamination risk fell under Yellow List conditions. Those shipments required shipment-specific certification from a certifying entity designated by the FDA, and those certifications had to be submitted directly to the agency. That matters because it reduces the chance of weak paperwork, after-the-fact improvisation, or a mysterious “trust me, it’s fine” document appearing from nowhere.

Third-Party Audits and Foreign Government Role

Another interesting part of this move is how the FDA blends oversight models. The law allows certification to come from a foreign government agency or from an accredited third-party certification body, depending on what the agency requires. That creates a flexible system. In the shrimp and spices case, the FDA designated Indonesian government entities for certain shipment certifications while also requiring accredited third-party certification for firms seeking removal from the Red List.

That structure shows how the FDA can combine diplomacy, technical oversight, and trade management in one enforcement framework. It is not just checking products. It is shaping the system around those products.

What This Means for Food Importers

If you import food into the United States, this decision should get your attention even if you have never imported a single shrimp in your life. The FDA has now demonstrated that it is willing to activate a stronger FSMA tool when contamination appears linked to recurring regional risk. That means importers cannot assume existing border screening alone will remain the only line of defense in future high-risk cases.

For importers, the lessons are practical:

• Know your supplier chain in detail. “Somewhere over there” is not a compliance strategy.
• Map geographic risk. Region-specific contamination can trigger region-specific controls.
• Strengthen FSVP documentation. If FDA asks questions, vague confidence is not a document.
• Prepare for pre-shipment testing or certification. The old rhythm of border review may no longer be enough in certain cases.
• Coordinate early with brokers and legal teams. Waiting until the container is at the port is a famously bad time to discover new certification rules.

Brands and retailers should also care. A contaminated imported ingredient does not stop being a business problem just because somebody else packed the container. It can become a recall, a shelf pull, a consumer trust issue, and a public relations mess in record time.

How This Fits Into the Bigger FSMA Picture

The FDA’s move did not come out of nowhere. FSMA was built on a preventive philosophy. The law shifted food safety from a mostly reactive model toward a framework focused on stopping problems before they spread. That philosophy already shows up in preventive controls, produce safety rules, FSVP requirements, and the accredited third-party certification system.

Import certification fits neatly into that architecture. It is one of the law’s clearest examples of upstream prevention: identify a risk, require evidence that the risk is controlled, and make that evidence a condition of import. It is a far more modern approach than simply waiting for contaminated food to appear, testing a few samples, and hoping the rest of the system keeps up.

Seen this way, the FDA’s first use of the tool is not a strange one-off. It is actually FSMA growing into its full personality. And that personality is decidedly less casual than the older era of import oversight.

Could the FDA Use This Power Again?

Yes, and that is the real headline hidden underneath the headline. Now that the FDA has used this authority once, the mystery is gone. The tool is no longer theoretical. It is operational.

That does not mean the agency will start tossing import certification at every problem like confetti at a parade. The FDA has said the authority is meant for targeted, risk-based use. Still, the first use establishes a regulatory precedent. It shows the agency has a playbook, a rationale, and an implementation model it can adapt to future contamination events, regional breakdowns, or recurring imported food safety failures.

Potential future scenarios could involve chemical contamination, persistent pathogen concerns, environmental contamination events, or repeated failures tied to specific products and regions. If the FDA believes existing measures are not enough, the agency now has a proven example of how to escalate without shutting down all trade.

Why Consumers Should Care Too

Consumers may never read an import alert for fun, and honestly, that is probably a sign of a balanced life. But this change matters to shoppers because it reflects a stronger effort to keep unsafe imported food out of the U.S. market while preserving access to safe products.

That balance is important. Americans rely heavily on global food supply chains. Seafood, spices, produce, and ingredients often travel long distances before they reach a grocery store or restaurant. A modern food system needs a modern import safety system. The FDA’s first use of import certification suggests the agency is willing to build exactly that, even if the paperwork may now be sweating a little.

What This Feels Like on the Ground: Real-World Import Experience

In real-world terms, an FDA move like this rarely lands as a single dramatic moment. It lands as a series of very unglamorous phone calls. The customs broker wants the correct filing details. The food safety manager wants documentation. The importer wants to know whether the shipment can move. The supplier wants to know why yesterday’s process suddenly needs three extra layers of proof. And somewhere in the middle, somebody is staring at a spreadsheet with the haunted expression of a person who just learned the phrase “shipment-specific certificate” is now part of daily life.

For many companies, the first experience is confusion, not defiance. Teams are used to standard import checks, prior notice requirements, routine entry screening, and the normal give-and-take of compliance. Import certification changes the rhythm. Instead of reacting when a shipment is flagged, companies need to prove ahead of time that the product is admissible under the new conditions. That means operational changes, not just legal awareness.

A quality assurance team might suddenly need to coordinate more tightly with overseas processors. A sourcing team may have to verify exactly where products were harvested, packed, or held, because regional scope matters. A broker may need certificates submitted in a specific system and matched correctly to the entry. If one data field is wrong, the shipment can get stuck, and perishable goods do not exactly enjoy surprise vacations at the port.

There is also the reputational stress. Importers know that once contamination concerns hit the news, every customer starts asking sharper questions. Retailers want assurances. Distributors want timelines. Restaurant buyers want to know whether alternate supply is available. Nobody wants to be the person saying, “We are still waiting to understand the paperwork situation,” while a purchase order hangs in limbo.

On the supplier side, the experience can be just as intense. Foreign firms may feel that they are being judged not only on their own practices, but also on the conditions of a broader region. That can be frustrating, especially for companies that believe their internal controls are strong. But from the FDA’s point of view, regional risk is exactly the point. When contamination may be systemic or environmental, the agency is not just evaluating one factory’s confidence level. It is evaluating whether the overall risk profile requires more assurance before products move.

For seasoned compliance professionals, however, there is another reaction after the initial groan: clarity. A stricter system can be painful, but it can also be workable if the rules are specific. Once companies understand what documents are required, who can issue them, how they must be submitted, and what conditions must be met for release, they can redesign their processes around the requirement. It becomes less of a panic and more of a protocol.

That may end up being the long-term experience that defines this FDA action. Not chaos, but adjustment. Not a permanent trade freeze, but a tougher standard for proving safety. And in food imports, that distinction matters. Companies can plan around clear rules. What they struggle with is uncertainty. By using import certification for the first time, the FDA made the system stricter, yes, but it also made its expectations more visible. For importers who want to stay in the U.S. market, that visibility is likely to be uncomfortable, expensive, and ultimately useful.

Conclusion

The first use of FDA’s added import certification authority is more than a niche regulatory milestone. It is a sign that imported food safety is entering a more preventive, more document-driven, and more risk-targeted phase. The agency did not just react to contamination concerns involving shrimp and spices from Indonesia. It showed that when a threat appears ongoing and serious, it is willing to push controls upstream and require stronger proof before products enter U.S. commerce.

That matters for regulators, importers, foreign suppliers, retailers, and consumers alike. It means the FDA’s toolbox is no longer theoretical. It is active. And now that this power has been used once, the rest of the food import world has every reason to assume it could be used again. In the language of compliance, that is called a precedent. In the language of everyone else, it is called a wake-up call.